Signal from the log
Dialybrid
15 M€ · Series A · Italy · Medtech
Dialybrid fabrique un greffon vasculaire en Silkothane, un matériau qui mêle fibroïne de soie et polyuréthane, pour l'accès vasculaire des patients en hémodialyse. Il vise à remplacer les greffons synthétiques et les fistules natives. Le premier patient a été implanté dans un essai italien.
Verified
Announced on , logged by the watch of 22 September 2026.
- Operation
- Funding round
- Announced amount
- 15 M€
- Stage
- Series A
- Country
- Italy
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by XGEN Venture , with CDP Venture Capital, fonds Rilancio
Provenance
Source fortune
Logged on 22 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.